Evaluation of atrial conduction time by P wave dispersion and tissue Doppler echocardiography in prehypertensive patients;Prehipertansif hastalarda atriyal ileti süresinin doku Doppler ekokardiyografi ve P dalga dispersiyonu ile deǧerlendirilmesi

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 8, 2010, Pages 525-530

  Ermiş, Necip ^a   Açikgöz, Nusret ^a   Yaşar, Erdoǧan ^a   Taşolar, Hakan ^a   Yaǧmur, Jülide ^a   Cansel, Mehmet ^a   Ataş, Halil ^a   Pekdemir, Hasan ^a   Özdemir, Ramazan ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Echocardiography, Doppler; Electrocardiography; Heart atria pathology; Heart conduction system pathology; Hypertension complications

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HUMAN; MALE; P WAVE; PREHYPERTENSION; TISSUE DOPPLER IMAGING; TRICUSPID VALVE;

ATRIAL FIBRILLATION; ATRIAL FUNCTION; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PREHYPERTENSION; RISK FACTORS;

EID: 79960053964     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Köse S, Aytemir K, Sade E, Can İ, Özer N, Amasyali B, et al. Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion. Clin Cardiol 2003;26:431-4. (Pubitemid 37072058)
2. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-8. (Pubitemid 28237295)
3. Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol 2005;38:43-6. (Pubitemid 40127175)
4. Tükek T, Akkaya V, Atilgan D, Demirel S, Sözen AB, Kuda H, et al. Changes in P wave dispersion, left atrial size and function in hypertensive patients with paroxysmal atrial fibrillation. [Article in Turkish] Türk Kardiyol Dern Arş 2000;28:538-42.
5. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
6. Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J 2000;139:814-9. (Pubitemid 30305402)
7. Dilaveris PE, Gialafos EJ, Chrissos D, Andrikopoulos GK, Richter DJ, Lazaki E, et al. Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis. J Hypertens 1999;17:1463-70. (Pubitemid 29509493)
8. Özer N, Yavuz B, Can I, Atalar E, Aksöyek S, Ovünç K, et al. Doppler tissue evaluation of intra-atrial and interatrial electromechanical delay and comparison with P-wave dispersion in patients with mitral stenosis. J Am Soc Echocardiogr 2005;18:945-8. (Pubitemid 41253946)
9. Cui QQ, Zhang W, Wang H, Sun X, Wang R, Yang HY, et al. Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol 2008;31:74-8. (Pubitemid 351317216)
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
11. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6. (Pubitemid 33124327)
12. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.
13. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
14. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 1985;254:3449-53.
15. Tükek T, Akkaya V, Demirel S, Sözen AB, Kudat H, Atilgan D, et al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation Am J Cardiol 2000;85:896-9.
16. Şenen K, Turhan H, Riza Erbay A, Başar N, Saatçi Yasar A, Şahin O, et al. P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail 2004;6:567-9. (Pubitemid 39070510)
17. Erbay AR, Turhan H, Yaşar AS, Biçer A, Senen K, Şaşmaz H, et al. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis. Int J Cardiol 2005;102:33-7. (Pubitemid 40812913)
18. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
19. Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-77. (Pubitemid 32144209)
20. Neaton JD, Kuller L, Stamler J, Wentworth DN. Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. Vol. 1, 2nd ed. New York: Raven Press; 1995. p. 127-44.
21. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006;47:410-4. (Pubitemid 43740283)
22. Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, et al. Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med 1977;296:405-11.
23. Julius S, Krause L, Schork NJ, Mejia AD, Jones KA, van de Ven C, et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991;9:77-84.
24. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388-93.
25. Kelm M, Schäfer S, Mingers S, Heydthausen M, Vogt M, Motz W, et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 1996;14:1357-64. (Pubitemid 26377221)
26. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A, et al. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 2003; 284:H1313-20.
27. Dilaveris P, Batchvarov V, Gialafos J, Malik M. Comparison of different methods for manual P wave duration measurement in 12-lead electrocardiograms. Pacing Clin Electrophysiol 1999;22:1532-8.